SpringWorks Therapeutics, Inc. (SWTX)
NASDAQ: SWTX · IEX Real-Time Price · USD
37.72
+1.26 (3.46%)
At close: Jul 19, 2024, 4:00 PM
37.76
+0.04 (0.11%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
SpringWorks Therapeutics Market Cap
SpringWorks Therapeutics has a market cap or net worth of $2.79 billion as of July 22, 2024. Its market cap has increased by 76.67% in one year.
Market Cap
2.79B
Enterprise Value
2.36B
1-Year Change
76.67%
Ranking
Category
Stock Price
$37.72
Market Cap Chart
Since September 13, 2019, SpringWorks Therapeutics's market cap has increased from $998.90M to $2.79B, an increase of 179.76%. That is a compound annual growth rate of 23.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.79B | 22.35% |
| Dec 29, 2023 | 2.28B | 40.77% |
| Dec 30, 2022 | 1.62B | -46.84% |
| Dec 31, 2021 | 3.05B | -13.69% |
| Dec 31, 2020 | 3.54B | 113.65% |
| Dec 31, 2019 | 1.66B | 65.71% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| agilon health | 2.83B |
| Morphic Holding | 2.83B |
| Tandem Diabetes Care | 2.82B |
| MorphoSys AG | 2.82B |
| MoonLake Immunotherapeutics | 2.81B |
| Bausch Health Companies | 2.79B |
| Apogee Therapeutics | 2.78B |
| Geron | 2.73B |